Основные параметры
P/E |
877.75 |
P/S |
30.01 |
P/BV |
24.8 |
EV/EBITDA |
479.98 |
EBITDA |
0.0098 |
Цена ао |
105.33 |
Оценка
|
Недооценка
Название |
Значение |
Оценка |
P/S |
30.01 |
1 |
P/BV |
24.8 |
1 |
P/E |
877.75 |
1 |
EV/EBITDA |
479.98 |
1 |
|
|
|
|
Эффективность
Название |
Значение |
Оценка |
ROA, % |
1.8 |
1 |
ROE, % |
3.31 |
1 |
|
|
|
|
|
Дивиденды
Название |
Значение |
Оценка |
Div yield, % |
|
0 |
DSI |
0 |
0 |
|
|
|
|
Долг
Название |
Значение |
Оценка |
Долг/EBITDA |
|
0 |
|
|
|
|
Импульс роста
Название |
Значение |
Оценка |
Рост прибыли, % |
0 |
0 |
Рост цены акции, % |
0 |
0 |
Рост дивидендов, % |
0 |
0 |
|
|
|
|
Основные владельцы
Institutions |
Объем |
Доля, % |
Sumitomo Mitsui DS Asset Management Company, Limited |
337100 |
0.21 |
T. Rowe Price Associates, Inc. |
20448000 |
12.74 |
Asset Management One Co., Ltd. |
518700 |
0.32 |
Aberdeen Standard Investments Limited |
53400 |
0.03 |
FIL Fund Management Limited |
112615 |
0.07 |
FIL Life Insurance Limited |
126434 |
0.08 |
T. Rowe Price |
14521600 |
9.05 |
Schroder Investment Management(Japan)Ltd |
109700 |
0.07 |
Aberdeen |
180500 |
0.11 |
Nikko Asset Management Co Ltd |
2052800 |
1.28 |
RMB Capital Management, LLC |
140600 |
0.09 |
FIL Investments (Japan) Limited |
1652000 |
1.03 |
Aberdeen Asset Mgmt |
94800 |
0.06 |
Investors Group Inc |
289000 |
0.18 |
Aberdeen Asset Managers Ltd |
94800 |
0.06 |
Harding Loevner LP |
533115 |
0.33 |
Evli Fund Management Company Oy |
25600 |
0.02 |
Standard Life Assurance Company |
2570000 |
1.6 |
BlackRock Fund Advisors |
3900197 |
2.43 |
Aberdeen Standard Investments Luxembourg S.A. |
553143 |
0.34 |
Aberdeen Standard Investments (Asia) Limited |
4900 |
0 |
Harding Loevner L.P. |
21255 |
0.01 |
BlackRock Advisors (UK) Limited |
698456 |
0.43 |
Aberdeen Standard Investments Inc. |
2104 |
0 |
SunAmerica Asset Management, LLC |
170200 |
0.11 |
Ivy Investment Management Company |
148500 |
0.09 |
Содержится в ETF
Похожие компании
Описание STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Lake Forest, California.